Modernizing Medicare Part D

During this congressional lunch briefing, analysts will outline the mechanisms of the Medicare Part D program under current law and discuss the potential implications of reforms put forward by Congress and the administration.

Basics of Biosimilars

During this briefing, panelists explained the mechanisms of biologic drugs, explore the impact of current regulations on the uptake of biosimilars, and discuss considerations for the biosimilars market in the United States.

Our 2018 Speakers

Summit on Health Care Costs in America

The conversation on health care costs in America is decades old, yet progress has been elusive. Terms like sustainability, affordability, and value are set forward as goals, but perspectives on how to achieve them vary widely. Speakers and panelists will provide insights on current and projected health care cost trends, what different stakeholders hope to achieve, and new approaches to consider.

Competition and Consolidation: Understanding Recent Trends in the Health Care Market

This is the first webinar, part of the Beyond the Beltway: Health Webinars for Journalists series, focused on the implications and tradeoffs of the recent trends in the health care market. Panelists helped define the basics of market concentration and competition, how experts measure the effects on different areas of the market, and how regulators approach assessing partnership proposals.

Navigating Next Steps on Payment Reform

This briefing provided an update on the overall state of play with payment reform, and the effort to move away from fee for service and toward value-based payment. Panelists discussed the interplay between the public and private sectors, and, given likely future directions for the CMS Center for Medicare and Medicaid Innovation, highlighted areas where the private sector may be best positioned to lead. Panelists shared what this means for future policy options and needs.

Medicare and Prescription Drug Prices

This briefing featured presentations by our experts highlighting the trends in Medicare regarding prescription drug pricing, and panelists discussed an array of policy options to align drug prices with value through alternative payment models.

Assessing Innovations in Medicaid

Medicaid is testing numerous new alternative payment and delivery system models to enhance the coordination of the health care services provided to millions of low-income Americans. This briefing examined the range of Medicaid’s efforts to improve care and promote value, including integrating health with non-clinical and behavioral services, creating managed care organizations, and instituting regional care collaborative organizations. Our panel also addressed Medicaid’s role in managing emerging issues such as the opioid epidemic and the spread of the Zika virus.

High-Need, High-Cost Patients: Challenges & Promising Models

Health systems have applied many innovative new strategies for improving quality and reducing costs when it comes to care for high-need, high-cost patients, who typically have multiple chronic conditions. Which of these innovations show promise, and what can we learn from them?